Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Fluorine-18 (F) is undoubtedly one of the most frequently applied radionuclides for the development of new radiotracers for positron emission tomography (PET) in the context of clinical cancer, neurological, and metabolic imaging. Until recently, the available radiochemical methodologies to introduce F into organic molecules ranging from small- to medium- and large-sized compounds were limited to a few applicable protocols. With the advent of late-stage fluorination of small aromatic, nonactivated compounds and various noncanonical labeling strategies geared toward the labeling of peptides and proteins, the molecular toolbox for PET radiotracer development was substantially extended. Especially, the noncanonical labeling methodologies characterized by the formation of Si-F, B-F, and Al-F bonds give access to kit-like F-labeling of complex and side-group unprotected compounds, some of them already in clinical use. This chapter will particularly focus on silicon-fluoride acceptor (SiFA) chemistry and cover the history of its conceptual design and its translation into the clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-3499-8_3DOI Listing

Publication Analysis

Top Keywords

noncanonical labeling
8
silicon-fluoride acceptors
4
acceptors sifa
4
sifa f-radiolabeling
4
f-radiolabeling bench
4
bench bedside
4
bedside fluorine-18
4
fluorine-18 undoubtedly
4
undoubtedly frequently
4
frequently applied
4

Similar Publications

Antigen-binding proteins, such as nanobodies, modified with functional small molecules hold great potential for applications including imaging probes, drug conjugates, and localized catalysts. However, traditional chemical labeling methods that randomly target lysine or cysteine residues often produce heterogeneous conjugates with limited reproducibility. Conventional site-specific conjugation approaches, which typically modify only the N- or C-terminus, may also be insufficient to achieve the desired functionalities.

View Article and Find Full Text PDF

Plants have evolved to produce diverse molecules that inhibit protein translation. A lead example is homoharringtonine (HHT), both a key tool for ribosomal profiling and an FDA-approved treatment for chronic myeloid leukemia. HHT is commercially produced through semi-synthesis by esterifying the alkaloid core cephalotaxine (CET) extracted from endangered species.

View Article and Find Full Text PDF

Endoplasmic reticulum unfolded protein responses contribute to cancer development, with activating transcription factor 6 (ATF6) involved in microbiota-dependent tumorigenesis. Here we show the clinical relevance of ATF6 in individuals with early-onset and late colorectal cancer, and link ATF6 signalling to changes in lipid metabolism and intestinal microbiota. Transcriptional analysis in intestinal epithelial cells of ATF6 transgenic mice (nATF6) identifies bacteria-specific changes in cellular metabolism enriched for fatty acid biosynthesis.

View Article and Find Full Text PDF

Antigen escape in CAR-T therapy: A tumor microenvironment perspective from hematological to solid tumors.

Int J Cancer

August 2025

Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.

Chimeric antigen receptor T-cell (CAR-T) therapy has shown remarkable efficacy in hematologic malignancies, but antigen escape remains a major challenge, especially in solid tumors, where the tumor microenvironment (TME) exacerbates the problem. Mechanisms of antigen escape include antigen loss, epitope masking, lineage switching, and trogocytosis-mediated CAR dysfunction. The TME promotes immune evasion through physical barriers, immunosuppressive cells, and metabolic competition.

View Article and Find Full Text PDF

This work reports the first electroanalytical methodology developed to determine global levels of G-quadruplex (G4) motifs in DNA, hitherto underestimated noncanonical structures of increasing relevance both in cancer diagnostics and precision therapy. The methodology developed takes advantage of the benefits provided by magnetic microcarriers to implement a competitive immunoassay involving a synthetic DNA sequence carrying a single G4 motif and a commercial recombinant antibody that can recognize these motifs. This antibody was enzymatically labeled with an HRP-conjugated secondary antibody, and amperometric transduction was performed using disposable electrode substrates.

View Article and Find Full Text PDF